Hi-Tech Lawsuit Calls FDA DMAA Enforcement “Bullying Tactics”
This article was originally published in The Tan Sheet
Executive Summary
Hi-Tech Pharmaceuticals files a lawsuit in federal court after receiving an administrative detention order from FDA to stop distributing its DMAA-containing products. The firm argues FDA should conduct a rulemaking to propose banning DMAA rather than ordering firms to stop using it.